Oorsprong van het eerstegraads netwerk van Robert Kopple
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is a holding company. The private company is based in London, UK and was founded in 2014.
5
| Private Company | Financial Conglomerates | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Robert Kopple via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member Chief Executive Officer | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Deepbridge Capital LLP
 Deepbridge Capital LLP Investment ManagersFinance Deepbridge Capital LLP (Deepbridge) is an investment management firm founded in 2010. The firm is headquartered in Chester, UK. | Investment Managers | Consultant / Advisor Investment Committee Member | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer Comptroller/Controller/Auditor | |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Medical/Nursing Services | Founder | |
| Baines Peter Consulting | Director/Board Member | ||
| The University of Sheffield | College/University | Undergraduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Chief Executive Officer | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| KROMEK GROUP PLC | Medical Specialties | Director/Board Member | |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Director/Board Member | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
| INDIVIOR PLC | Pharmaceuticals: Major | Director/Board Member | |
| Apterna Ltd. | Director/Board Member | ||
| BIOCON LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
ILC Therapeutics Ltd.
 ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Chairman | |
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Imperial College Healthcare NHS Trust
 Imperial College Healthcare NHS Trust Hospital/Nursing ManagementHealth Services Imperial College Healthcare NHS Trust is a non-profit organization which provides community and healthcare services. It offers cardiology, endocrinology, melanoma, maternity ultrasound, maternal medicine, and major trauma center. The organization was founded on October 1, 2007 and is headquartered in London, the United Kingdom. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Imperial College London | College/University | Corporate Officer/Principal | |
EMcision Ltd.
 EMcision Ltd. Medical SpecialtiesHealth Technology EMcision Ltd. develops medical devices. Its products include Habib EndoHPB, Endoblate, VesCoag, VesOpen, Percutaneous HPB, and EUS RFA. The firm's products are used for laparoscopic, vascular and endoscopic surgeries. It serves in the area of research and development and commercial sectors. The company was founded by Nagy Habib on June 16, 1999 and is headquartered in London, the United Kingdom. | Medical Specialties | Founder | |
Thirty Holdings Ltd.
 Thirty Holdings Ltd. Packaged SoftwareTechnology Services Thirty Holdings Ltd. operates as a holding British company whose subsidiary develops an anti-infective nitric oxide technology platform for the healthcare sector. The company is based in London, UK. The company was founded in 2018 by Christopher Barry Wood. | Packaged Software | Founder | |
| Genethics Ltd. | Founder | ||
| Oncobiopharm Ltd. | Chairman | ||
MedAnnex Ltd.
 MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Founder | |
EdixoMed Ltd.
 EdixoMed Ltd. BiotechnologyHealth Technology Part of Mativ Holdings, Inc., EdixoMed Ltd. engages in research and development of biotechnology. The company is based in Edinburgh, UK. The British company was founded by Hugh Stephen Griffith. | Biotechnology | Chairman | |
| Cardiff University School of Medicine | College/University | Doctorate Degree | |
| Eurobiotech, Inc. | Chief Executive Officer | ||
| NUCANA PLC | Biotechnology | Founder | |
| University of Bath | College/University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 26 |
| Verenigde Staten | 5 |
| India | 5 |
| Japan | 2 |
| Australië | 2 |
Sectoraal
| Health Technology | 20 |
| Consumer Services | 5 |
| Commercial Services | 4 |
| Finance | 3 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 27 |
| Chairman | 12 |
| Founder | 8 |
| Chief Executive Officer | 6 |
| Corporate Officer/Principal | 5 |
Sterkste connecties
| Insiders | |
|---|---|
| Peter Bains | 19 |
| Christopher Barry Wood | 16 |
| Nagy Habib | 6 |
| Kieran Johnson | 5 |
| Robert Sebastian Habib | 2 |
- Beurs
- Insiders
- Robert Kopple
- Bedrijfsconnecties
